BCAT1 deletion combined with αKG is a new synthetic lethal method for the treatment of IDHwt GBM. The decrease in the expression of BCAT1 reduces the supply of glutamate, increases the dependence on glutaminase, and reduces tumor proliferation and invasion. This evidence concerns the gene GLS and glioblastoma.